Triple-Negative Breast Cancer
Top Cited Papers
- 11 November 2010
- journal article
- review article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 363 (20), 1938-1948
- https://doi.org/10.1056/nejmra1001389
Abstract
Triple-negative breast cancer, so called because it lacks expression of the estrogen receptor, progesterone receptor, and HER2, is often, but not always, a basal-like breast cancer. This review focuses on its origin, molecular and clinical characteristics, and treatment.Keywords
This publication has 61 references indexed in Scilit:
- Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targetsOncogene, 2010
- The molecular underpinning of lobular histological growth pattern: a genome‐wide transcriptomic analysis of invasive lobular carcinomas and grade‐ and molecular subtype‐matched invasive ductal carcinomas of no special typeThe Journal of Pathology, 2009
- Gene-Expression Signatures in Breast CancerThe New England Journal of Medicine, 2009
- Basal-Like Breast Cancer: A Critical ReviewJournal of Clinical Oncology, 2008
- How basal are triple‐negative breast cancers?International Journal of Cancer, 2008
- Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomasBreast Cancer Research, 2007
- Molecular Classification and Molecular Forecasting of Breast Cancer: Ready for Clinical Application?Journal of Clinical Oncology, 2005
- Molecular portraits of human breast tumoursNature, 2000
- Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomasVirchows Archiv, 1998
- MONOCLONAL MARKER THAT PREDICTS EARLY RECURRENCE OF BREAST CANCERThe Lancet, 1987